Back to top of page

Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)

List of Required Information for Application:

1. Title of the project proposal

2. Principal Investigator (PI) information (name, contact details, affiliations)

3. Co-investigator information (if applicable)

4. Abstract of the proposed research project

5. Specific aims and objectives of the study

6. Background and significance of the study and its relevance to the field of AD/ADRD and COVID-19

7. Research plan and methodology (including animal models, cell culture models, and/or human tissue models)

8. Description of how the proposed study will incorporate AD/ADRD risk factors, pathologies, or comorbidities

9. Detailed description of the mechanistic studies that will be conducted to address the impact, acceleration, or predisposition of AD/ADRD by COVID-19

10. Strategies to assess CNS pathology and cognitive outcomes in the presence of COVID-19 and AD/ADRD pathology

11. Potential implications and benefits of the proposed research for understanding the interaction between COVID-19 and AD/ADRD

12. Timeline and milestones for the project

13. Budget and budget justification

14. Description of resources and facilities available to conduct the research

15. Ethical considerations and proposed measures for the welfare and care of research subjects (if applicable)

16. References supporting the proposed research and prior relevant work by the research team

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows